Involvement of Genetic Factors in Multiple Sclerosis

Overview

Journal Front Cell Neurosci

Specialty Cell Biology

Date 2020 Dec 18

PMID 33335478

Citations 5

Authors

Laura Ferre

Massimo Filippi

Federica Esposito

Affiliations

Soon will be listed here.

Citing Articles

The Potential of Transcranial Direct Current Stimulation (tDCS) in Improving Quality of Life in Patients with Multiple Sclerosis: A Review and Discussion of Mechanisms of Action.

Chmiel J, Kurpas D, Stepien-Slodkowska M J Clin Med. 2025; 14(2).

PMID: 39860377 PMC: 11766291. DOI: 10.3390/jcm14020373.

Genes, Gene Loci, and Their Impacts on the Immune System in the Development of Multiple Sclerosis: A Systematic Review.

Arneth B Int J Mol Sci. 2024; 25(23).

PMID: 39684620 PMC: 11641802. DOI: 10.3390/ijms252312906.

The role of inflammation in neurological disorders: a brief overview of multiple sclerosis, Alzheimer's, and Parkinson's disease'.

Cantero-Fortiz Y, Boada M Front Neurol. 2024; 15:1439125.

PMID: 39539666 PMC: 11558529. DOI: 10.3389/fneur.2024.1439125.

The role of parental consanguinity and familial aggregation in development of multiple sclerosis: a case-control study.

Vaheb S, Yazdan Panah M, Afshari-Safavi A, Moases Ghaffary E, Shaygannejad A, Shaygannejad V Eur J Med Res. 2024; 29(1):503.

PMID: 39420388 PMC: 11488231. DOI: 10.1186/s40001-024-02094-x.

Mitochondrial Dynamics in Neurodegenerative Diseases: Unraveling the Role of Fusion and Fission Processes.

Grel H, Woznica D, Ratajczak K, Kalwarczyk E, Anchimowicz J, Switlik W Int J Mol Sci. 2023; 24(17).

PMID: 37685840 PMC: 10487704. DOI: 10.3390/ijms241713033.

References

Gu X, Yao H, Haddad G . Increased neuronal excitability and seizures in the Na(+)/H(+) exchanger null mutant mouse. Am J Physiol Cell Physiol. 2001; 281(2):C496-503. DOI: 10.1152/ajpcell.2001.281.2.C496. View

Dilokthornsakul P, Valuck R, Nair K, Corboy J, Allen R, Campbell J . Multiple sclerosis prevalence in the United States commercially insured population. Neurology. 2016; 86(11):1014-21. PMC: 4799713. DOI: 10.1212/WNL.0000000000002469. View

Beecham A, Patsopoulos N, Xifara D, Davis M, Kemppinen A, Cotsapas C . Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet. 2013; 45(11):1353-60. PMC: 3832895. DOI: 10.1038/ng.2770. View

Weber F, Fontaine B, Cournu-Rebeix I, Kroner A, Knop M, Lutz S . IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations. Genes Immun. 2008; 9(3):259-63. DOI: 10.1038/gene.2008.14. View

Clarelli F, Liberatore G, Sorosina M, Osiceanu A, Esposito F, Mascia E . Pharmacogenetic study of long-term response to interferon-β treatment in multiple sclerosis. Pharmacogenomics J. 2015; 17(1):84-91. DOI: 10.1038/tpj.2015.85. View

Naito S, NAMEROW N, Mickey M, Terasaki P . Multiple sclerosis: association with HL-A3. Tissue Antigens. 1972; 2(1):1-4. DOI: 10.1111/j.1399-0039.1972.tb00111.x. View

Grossman I, Avidan N, Singer C, Goldstaub D, Hayardeny L, Eyal E . Pharmacogenetics of glatiramer acetate therapy for multiple sclerosis reveals drug-response markers. Pharmacogenet Genomics. 2007; 17(8):657-66. DOI: 10.1097/FPC.0b013e3281299169. View

Gregory S, Schmidt S, Seth P, Oksenberg J, Hart J, Prokop A . Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet. 2007; 39(9):1083-91. DOI: 10.1038/ng2103. View

Gross R, Healy B, Cepok S, Chitnis T, Khoury S, Hemmer B . Population structure and HLA DRB1 1501 in the response of subjects with multiple sclerosis to first-line treatments. J Neuroimmunol. 2010; 233(1-2):168-74. DOI: 10.1016/j.jneuroim.2010.10.038. View

10.

Henderson A, Barnett M, Parratt J, Prineas J . Multiple sclerosis: distribution of inflammatory cells in newly forming lesions. Ann Neurol. 2009; 66(6):739-53. DOI: 10.1002/ana.21800. View

11.

Fogdell-Hahn A, Ligers A, Gronning M, Hillert J, Olerup O . Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens. 2000; 55(2):140-8. DOI: 10.1034/j.1399-0039.2000.550205.x. View

12.

Hauser S, Oksenberg J, Lincoln R, Garovoy J, Beck R, Cole S . Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS. Optic Neuritis Study Group. Neurology. 2000; 54(9):1859-61. DOI: 10.1212/wnl.54.9.1859. View

13.

Jersild C, Svejgaard A, FOG T . HL-A antigens and multiple sclerosis. Lancet. 1972; 1(7762):1240-1. DOI: 10.1016/s0140-6736(72)90962-2. View

14.

. Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk. Cell. 2018; 175(6):1679-1687.e7. PMC: 6269166. DOI: 10.1016/j.cell.2018.09.049. View

15.

Byun E, Caillier S, Montalban X, Villoslada P, Fernandez O, Brassat D . Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis. Arch Neurol. 2008; 65(3):337-44. DOI: 10.1001/archneurol.2008.47. View

16.

Jensen C, Stankovich J, van der Walt A, Bahlo M, Taylor B, van der Mei I . Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients. PLoS One. 2010; 5(4):e10003. PMC: 2848851. DOI: 10.1371/journal.pone.0010003. View

17.

. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet. 2009; 41(7):824-8. DOI: 10.1038/ng.396. View

18.

Mahurkar S, Moldovan M, Suppiah V, Sorosina M, Clarelli F, Liberatore G . Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study. Pharmacogenomics J. 2016; 17(4):312-318. DOI: 10.1038/tpj.2016.20. View

19.

Martinez A, de las Heras V, Mas Fontao A, Bartolome M, de la Concha E, Urcelay E . An IFNG polymorphism is associated with interferon-beta response in Spanish MS patients. J Neuroimmunol. 2006; 173(1-2):196-9. DOI: 10.1016/j.jneuroim.2005.12.002. View

20.

Tsareva E, Kulakova O, Boyko A, Shchur S, Lvovs D, Favorov A . Allelic combinations of immune-response genes associated with glatiramer acetate treatment response in Russian multiple sclerosis patients. Pharmacogenomics. 2011; 13(1):43-53. DOI: 10.2217/pgs.11.136. View